Complete Story
 

Course Descriptions - 2006 OPA Annual Conference

FRIDAY, April 21

 

8:30 a.m.
CE Credit per Program: 0.2 CEU

Borderline Personality Disorder
Randy A. Sansone, M.D.
Professor, Psychiatry & Internal Medicine,
WrightState University School of Medicine
This program will focus on the description, clinical identification, and management of individuals suffering from borderline personality disorder. The inherent self-regulation difficulties among these individuals, and the resulting risk of prescription and illicit substance use, will be highlighted.
ACPE #129-000-06-016-L01
Sponsor: Pfizer, Inc.

 

Pharmacist Care: Is It Taking You to Pharmacy's True North?
William N. Tindall, Ph.D., R.Ph., Professor, Wright State University
Marsha K. Millonig, MBA, R.Ph., President, Catalyst Enterprises LLC
Pharmacy's "True North" can be found by keeping true to the direction that leads to fulfillment of the professional covenant of pharmacist care. This session will help you rekindle both your personal and professional passion, and motivate you to positively impact patient care through medication therapy management (MTM).
ACPE #129-000-06-017-L04
Sponsor: Merck & Co.

 

Quality Standards in Pharmacy: PQC Program and PCAB
Ken Baker, R.Ph., J.D.
Director, Pharmacy Compounding Accreditation Board
All pharmacies experience dispensing errors. This program will help you identify where the errors are occurring and how the Pharmacy Quality Commitment (PQC) Program will help train staff to check each step of the dispensing process and to document any errors using a web-based tool. Compounding accreditation was created as another quality standard in pharmacy to help assure high quality in pharmacy compounding. This speaker will explain the purpose and role of the new Pharmacy Compounding Accreditation Board (PCAB).
ACPE #129-000-06-018-L04
Sponsor: Analytical Research Laboratories

 

Multiple Sclerosis: Facts, Treatment, Services
Beth M. Spyke, MPA, LNHA, Program Manager, National MS Society, Ohio Buckeye Chapter and Geoffrey A. Eubank, M.D., Neurological Associates, Columbus
Multiple Sclerosis (MS) is a chronic, unpredictable neurological disease that affects over 15,000 individuals in Ohio. This program will outline diagnosis of MS, the importance of early treatment with disease-modifying therapies, treatment options on the horizon, as well as programs and services available to individuals with MS.
ACPE #129-000-06-019-L01
Sponsor: National MS Society, Ohio Buckeye Chapter


10:30 a.m.
CE Credit per Program: 0.2 CEU

 

 

Pharmacotherapeutic Dilemmas
Vincent F. Mauro, Pharm.D.
Professor of Clinical Pharmacy, University of Toledo College of Pharmacy
Using case study format, this session will apply pharmacotherapeutic and pharmacologic knowledge to avoid potential pharmacotherapeutic misadventures, and will help the pharmacist recognize clinically significant or unique drug interactions.
ACPE #129-000-06-020-L01

Clinical Case Studies in Compounding
Jim Paoletti, R.Ph.
VP, Director of Continuing Education and Consultant, PCCA
This program will include a review of case studies demonstrating effective therapeutic outcomes with compounded therapies. Case study topics will include pain management, bio-identical hormone replacement for women, men's health, veterinary compounding, wound healing and more. Whether you are currently practicing compounding or wish to get involved, this program is for you.
ACPE #129-000-06-021-L01
Sponsor: PCCA

Pharmacist Care: Planning Your Journey to Personal and Professional Success
William N. Tindall, Ph.D., R.Ph., Professor, Wright State University
Marsha K. Millonig, MBA, R.Ph., President, Catalyst Enterprises LLC
This interactive workshop is designed to help pharmacists and pharmacy students reset their personal compass so they can find themselves heading in a direction toward a more satisfying professional career. The exercises will explore ways to deal with change, establish achievable goals, and find personal and professional success while delivering pharmacist care.
ACPE #129-000-06-022-L04
Sponsor: Merck & Co.

 

 

 

Multi-Symptom Management in the End-of-Life Patient: From Pharmacology to Clinical Application
Marc Sweeney, R.Ph., Pharm.D.
Chair and Associate Professor, University of Findlay Palliative Care Specialist
This program will focus on the pharmacologic management of the most common symptoms experienced in the terminally ill patient. In a clinical pearl format, common symptoms from patients with Parkinson's Disease, Alzheimer's Disease, heart failure, diabetes mellitus, chronic obstructive lung disease, and cancer will be discussed. Pathophysiology will be integrated into pharmacologic application.
ACPE #129-000-06-023-L01


2:00 p.m.
CE Credit per Program: 0.2 CEU

 

 

Pharmacy Robbery: Protecting Your Pharmacy and Yourself
Detective Dennis Luken
Warren County (Ohio) Drug Task Force
This program will identify the scope of prescription drug diversion, the top drugs of abuse, as well as how to identify forged or altered prescriptions or those obtained by deception. In addition, our speaker will explain how to protect your pharmacy from robbery, how to assess the physical security of your pharmacy, and how to be a good witness.
ACPE #129-000-06-024-L04
Sponsor: Purdue Pharma LP

OhioResearch Forum 2006
Moderator: Curtis Black, R.Ph., Ph.D.
Professor of Clinical Pharmacy, University of Toledo College of Pharmacy
Ohio pharmacists, college faculty, pharmacy residents and students showcase their cutting-edge pharmacy research in the Annual Ohio Research Forum. Topics include: disease state management, proper drug therapy, pharmacoeconomic issues, technology in the profession, innovative pharmacy services, and many others. This platform session will precede the Poster Session which immediately follows in the Exhibit Hall. ACPE #129-000-06-025-L04
Sponsor: Procter & Gamble

Vaccination Update 2006: Adding Pertussis & Meningitis
Joseph Dula, Pharm.D.
Pharmacy Systems, Inc., Pharmacist, Berger Health System, Circleville
Proper use of immunizations in adults can reduce the burden of disease in this population and help protect infants and children. Proposed legislation would enable Ohio pharmacists to administer pertussis and meningitis vaccines, in addition to influenza, pneumonia, tetanus, and hepatitis A and B. This session will provide an update of the current vaccines pharmacists can administer, plus an overview of pertussis and meningitis, including etiology, diagnosis, treatment, and new recommendations for prevention. In addition, Ohio's pandemic flu preparedness efforts will be covered. The H5N1 avian influenza (bird flu) circulating in Asia and Europe may spark the next pandemic, or a new strain may emerge.
ACPE #129-000-06-026-L01

 

Addiction: Signs & Symptoms, Drug Therapy, and Support for Recovering Pharmacy Professionals
Nick Kallis, R.Ph.
Pharmacists Rehabilitation Organization, Inc.
There are 18.6 million alcoholics and 7.7 million drug dependent persons in the U.S. today. Do you know what to do if one of them asks you for help? This session will review chemical dependency, including risk factors, signs & symptoms of addiction, and drug therapy used in recovering persons. Resources for assisting pharmacists and pharmacy interns who have addictions will also be discussed.
ACPE #129-000-06-027-L01
Sponsor: Pharmacists Rehabilitation Organization, Inc.



SATURDAY, April 22

 

8:30 a.m.
CE Credit per Program: 0.2 CEU

 

OhioDrug Database and Law Update 2006
(repeated at 10:30 a.m.)
William T. Winsley, R.Ph., Executive Director
Danna Droz, R.Ph., J.D., Prescription Monitoring Administrator
OhioStateBoard of Pharmacy
This important session for all pharmacists will address recent changes in state and federal laws and regulations which impact the practice of pharmacy. Topics will include the Dangerous Drug Database, compounding, drug repository program, charitable pharmacies, and the use of drug samples. You will have the opportunity to ask questions that apply specifically to your area of pharmacy practice. This program has been approved by the State Board of Pharmacy for 0.2 CEU of Ohio jurisprudence CE credit.
ACPE #129-000-06-028-L03

 

Disease, Illness and Irritable Bowel Syndrome: The Mind/Brain-Body/Gut Connections
William Salt, M.D.
Ohio Gastroenterology Group, Columbus
One in five Americans has irritable bowel syndrome (IBS), making it one of the most common disorders diagnosed by doctors. This session will provide an overview of IBS including its definition, how to distinguish it from other disorders, and the role of pharmaceuticals in treatment. Our speaker will also explore the biopsychosocialspiritual model of IBS: the linkage of health with stress, emotion, consciousness and soul through the mind/brain-body/gut connections.
ACPE #129-000-06-029-L01
Sponsor: Novartis Pharmaceuticals

 

Common Ophthalmic Conditions: OTC & Rx Treatment
Charles A. Hickey, M.D.
Columbus Ophthalmology Associates

Pharmacists are often frontline health professionals with common ophthalmic complaints such as dry and itchy eyes, and sties. Our speaker will provide information that will help pharmacists counsel patients on OTC ophthalmic products and know when to refer patients to physicians. Current treatment options for glaucoma will also be presented.
ACPE #129-000-06-030-L01
Sponsor: Alcon

 

Medication Therapy Management: Not Just for Medicare!
Jon Keeley, MS, R.Ph.
Vice President, Pharmacy Services, CareSource, Dayton
Scott Streator, R.Ph., MBA
Director of Health Care, Ohio Public Employees Retirement System
Pharmacists can look forward to various payers to recognize Medication Therapy Management Services (MTMS) as valuable for their clients. You will hear from two payers of pharmacy services, a managed care provider and an Ohio retirement system provider. CareSource is a managed care organization that believes pharmacists can help reduce their overall costs in treating patients in Medicaid. You will learn how pharmacist-MTMS will be integrated into their program. The Ohio Public Employees Retirement System also sees two-fold value in utilizing face-to-face pharmacist services. Ohio pharmacists can help their retirees with appropriate drug selection while producing tangible health savings that benefit the payer, the member, and our Ohio pharmacies.
ACPE #129-000-06-031-L04


10:30 a.m.
CE Credit per Program: 0.2 CEU

 

OhioDrug Database and Law Update 2006
(repeat of 8:30 a.m. program)

 

How Behavior Change Can Improve Patient Outcomes
ChristineBennett, M.S.
Corporate Fitness Consultant, Hackettstown, NJ
Do your patients think their medications alone will control diabetes, hyperlipidemia, or other chronic conditions? This interactive seminar will help pharmacists address patient personal behavior change in regards to healthy lifestyle behaviors and medication compliance. Our speaker will discuss the Behavior Change Model and strategies pharmacists can use for patients in each stage of change. Included are personal coaching techniques and exercises used to tap into a patient's personal motivation to elicit behavior change and improve outcomes.
ACPE #129-000-06-032-L04

 

Drug Therapy of Heart Failure based on Pharmacologic Mechanisms
Jon E. Sprague, R.Ph., Ph.D.
Chair and Professor of Pharmacology, Virginia College of Osteopathic Medicine & VirginiaTech University
Drug therapy of heart failure varies drastically from angiotensin converting enzyme inhibitors (ACEI) and β-blockers to vasodilators. The pharmacologic rationale for drug therapy will be reviewed based on drug mechanisms and the pathophysiology of heart failure. This program is intended to be a review of the fundamental pharmacological mechanisms of drugs affecting heart failure. New guidelines for treating heart failure will also be outlined.
ACPE #129-000-06-033-L01

 

Pharmacogenomics
Thomas Kupiec, Ph.D., CEO
Analytical Research Laboratories Pharmacogenomics is the study of interindividual genetic variations in drug disposition and the applications of these variations in selecting optimal drug therapy and dosage for each individual. This program will discuss how most drug effects are determined by the interaction of several gene products, with particular emphasis on the CYP450 enzyme system, and the current applications of pharmacogenomics and progress to future potential applications in varying fields.
ACPE #129-000-06-034-L01
Sponsor: International Journal of Pharmaceutical Compounding


2:30 p.m.
CE Credit per Program: 0.2 CEU

 

Pharmacist Prescribing
Debra Herman, Pharm.D., FASCP, R.Ph.
Director of Pharmacy Services
Pharmacist Clinician, LaCasa Family Health Center, Clovis, NM
Our speaker is a pharmacist clinician who has prescriptive authority in New Mexico. She will explain how she incorporates pharmacist-prescribing in her practice, how to structure a scope of practice, and how the board of pharmacy reviews potential candidates for prescriptive authority. This session will also provide background on the process of working with the Board of Medical Examiners to get the authority through the legislature. ACPE #129-000-06-035-L04

 

Diabetes Impact: The 2 Minute Consult
Steve Freed, R.Ph., CDE
Publisher, Diabetes in Control.com, Deerfield, IL
This program is intended to provide pharmacists with valuable, up-to-date information to enable them to rapidly and effectively teach patients how to improve their diabetes care. Our speaker will discuss reasons for the increase in diabetes diagnosis, the risk factors of pre-diabetes, physiology of glucose homeostasis, effects of food and exercise, benefits of glucose monitoring and A1c testing, as well as medications used in current therapies.
ACPE #372-000-04-005-L01
Note: Validated Statements of Continuing Pharmacy Education Credit for this program will be issued online by RxSchool. Complete details for obtaining the statement of credit will be distributed at the program to those in attendance.
Sponsor: Abbott Diabetes Care

 

Understanding the Basic Principles of Clinical Ethics
Donald L. Bennett, R.Ph., MBA
Quality Resource Manager, Pharmacy Systems, Inc, Dublin
Pharmacists in various practice settings are involved in end-of-life issues with patients and family members. This program will explain the legal basis for self determination; define advanced directives and living wills; and distinguish between ordinary/extraordinary means, killing/letting die, withholding/withdrawing, treatments/futility treatments. The elements of informed consent will be reviewed including investigational drug studies.
ACPE #129-000-06-037-L04

 

Herbs and Dietary Supplements: Integrating Natural Products Education into Pharmacy Practice
Bella H. Mehta, Pharm.D., Assistant Professor of Clinical Pharmacy
The Ohio State University
This program will teach pharmacists how to counsel patients regarding herbs/dietary supplements by applying literature-based information to patient case scenarios. The National Institute of Health's classifications of complementary and alternative medicine (CAM) will be reviewed, in addition to the development and implementation of CAM services by pharmacists. Safety and efficacy data on selected popular herbs/dietary supplements will be reviewed as well.
ACPE #129-000-06-038-L01



SUNDAY, April 23

8:30 a.m.
CE Credit per Program: 0.2 CEU

 

OhioMedicaid: Move to Managed Care and General Issues
Jeff Corzine, Health Systems Administrator
Office of Ohio Health Plans, Ohio Department of Job & Family Services
The majority of Medicaid patients will be moved into managed care during 2006. Current Medicaid fees will no longer apply, and many other changes will happen. This important program will give you the latest information on Medicaid managed care, and will also give you a chance to ask general questions about the program. If your pharmacy does significant Medicaid business, this program is essential to your success.
ACPE #129-000-06-039-L04

An Overview of Targeted Cancer Therapy: A Pharmacological and Clinical Perspective
Ryan Schneider, Pharm.D.
Graduate Student, The Ohio State University College of Pharmacy, Division of Pharmacology
Over the past decade great advances have been made in cancer research, which have led to the exciting potential for new cancer therapies. This session will focus on various innovative therapies including modification of cell signaling, immunotherapy, and gene therapy, which have the promise to target cancer exclusively. These therapies will be contrasted to the more non-specific cancer therapies used today.
ACPE #129-000-06-040-L01

 

OTC Use in Special Populations
Stefanie Ferreri, Pharm.D., CDE
Universityof North Carolina College of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics
Pharmacists play a key role in advising patients on the proper selection and safe use of over-the-counter medications. Recent news reports have indicated that OTC medicine ingredients have contributed to infant deaths in Ohio. This presentation will teach pharmacists how to counsel on the use of OTC products in special patient populations such as infants, young children, and pregnant females.
ACPE#129-000-06-041-L01
Sponsor: Procter & Gamble


10:30 a.m.
CE Credit per Program: 0.2 CEU

 

Update on New Drugs 2006
Karen L. Kier, Ph.D., M.Sc., R.Ph.
Professor of Clinical Pharmacy
Director, Drug Information
Ohio Northern University College of Pharmacy
In this annual new drug update, our speaker will examine the pharmacology and therapeutics of the medications released in the past year. The drugs? indications, adverse effects, drug interactions, as well as useful patient counseling tips will be outlined. A great deal of practical and immediately applicable information will be included in this presentation.
ACPE #129-000-06-042-L01

 

 

The Impact of Mental Illness on Physical Health
Anthony Restuccio, M.D.
Buchanan Medical Arts, Westerville
Depression is common in the general public, and even more common in medical patients. This program will examine the relationship between depression and comorbidities such as diabetes, cancer, stroke, and myocardial infarction. Our speaker will identify safe and effective treatment options which can decrease morbidity and mortality when patients are also treated for their mental illness and are compliant with their medications.
ACPE #129-000-06-043-L01

 

Poisons, Pe-ru-na, and Patent Medicines
Wayne Miller, R.Ph., Paul Wherry, R.Ph., Alan Katz, R.Ph. Pharmacy Antique Collectors, Columbus
Pharmacy history is of interest to pharmacists of all ages. This program will explore the early "trade card" drug advertisements, poisons previously used to treat common ailments, various patent medicines, and Pe-ru-na, an alcohol-based tonic owned by Dr. S. B. Hartman of Columbus. In addition, the speakers will explain how to start a collection of pharmacy antiques, and will discuss good pharmacy antique resources.
ACPE #129-000-06-044-L04

Printer-Friendly Version